vs

Side-by-side financial comparison of Comstock Holding Companies, Inc. (CHCI) and GERON CORP (GERN). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $23.9M, roughly 2.0× Comstock Holding Companies, Inc.). Comstock Holding Companies, Inc. runs the higher net margin — 56.3% vs -39.0%, a 95.3% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 41.5%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 50.0%).

The Comstock Lode is a lode of silver ore located under the eastern slope of Mount Davidson, a peak in the Virginia Range in Virginia City, Nevada, which was the first major discovery of silver ore in the United States and named after Canadian miner Henry Comstock.

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

CHCI vs GERN — Head-to-Head

Bigger by revenue
GERN
GERN
2.0× larger
GERN
$47.2M
$23.9M
CHCI
Growing faster (revenue YoY)
GERN
GERN
+25.5% gap
GERN
67.1%
41.5%
CHCI
Higher net margin
CHCI
CHCI
95.3% more per $
CHCI
56.3%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
50.0%
CHCI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CHCI
CHCI
GERN
GERN
Revenue
$23.9M
$47.2M
Net Profit
$13.5M
$-18.4M
Gross Margin
35.5%
Operating Margin
32.4%
-29.4%
Net Margin
56.3%
-39.0%
Revenue YoY
41.5%
67.1%
Net Profit YoY
30.5%
30.3%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCI
CHCI
GERN
GERN
Q4 25
$23.9M
Q3 25
$13.3M
$47.2M
Q2 25
$13.0M
$49.0M
Q1 25
$12.6M
$39.6M
Q4 24
$16.9M
Q3 24
$13.0M
$28.3M
Q2 24
$10.8M
$882.0K
Q1 24
$10.6M
$304.0K
Net Profit
CHCI
CHCI
GERN
GERN
Q4 25
$13.5M
Q3 25
$541.0K
$-18.4M
Q2 25
$1.4M
$-16.4M
Q1 25
$1.6M
$-19.8M
Q4 24
$10.3M
Q3 24
$2.4M
$-26.4M
Q2 24
$946.0K
$-67.4M
Q1 24
$910.0K
$-55.4M
Gross Margin
CHCI
CHCI
GERN
GERN
Q4 25
35.5%
Q3 25
11.0%
Q2 25
19.0%
Q1 25
18.6%
Q4 24
33.4%
Q3 24
26.3%
Q2 24
17.2%
Q1 24
16.5%
Operating Margin
CHCI
CHCI
GERN
GERN
Q4 25
32.4%
Q3 25
5.0%
-29.4%
Q2 25
13.7%
-25.4%
Q1 25
13.7%
-42.2%
Q4 24
30.1%
Q3 24
21.8%
-99.8%
Q2 24
11.4%
-7860.9%
Q1 24
10.8%
-18465.1%
Net Margin
CHCI
CHCI
GERN
GERN
Q4 25
56.3%
Q3 25
4.1%
-39.0%
Q2 25
11.1%
-33.4%
Q1 25
12.6%
-50.1%
Q4 24
61.1%
Q3 24
18.3%
-93.5%
Q2 24
8.8%
-7639.8%
Q1 24
8.6%
-18220.4%
EPS (diluted)
CHCI
CHCI
GERN
GERN
Q4 25
Q3 25
$-0.03
Q2 25
$-0.02
Q1 25
$-0.03
Q4 24
Q3 24
$-0.04
Q2 24
$-0.10
Q1 24
$0.09
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCI
CHCI
GERN
GERN
Cash + ST InvestmentsLiquidity on hand
$31.3M
$78.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$70.0M
$248.7M
Total Assets
$85.0M
$567.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCI
CHCI
GERN
GERN
Q4 25
$31.3M
Q3 25
$26.2M
$78.1M
Q2 25
$30.5M
$77.7M
Q1 25
$28.3M
$83.7M
Q4 24
$28.8M
Q3 24
$21.1M
$60.3M
Q2 24
$17.4M
$116.9M
Q1 24
$16.2M
$189.8M
Stockholders' Equity
CHCI
CHCI
GERN
GERN
Q4 25
$70.0M
Q3 25
$56.3M
$248.7M
Q2 25
$55.5M
$259.5M
Q1 25
$53.7M
$268.2M
Q4 24
$52.4M
Q3 24
$41.7M
$292.3M
Q2 24
$39.2M
$306.7M
Q1 24
$37.9M
$344.9M
Total Assets
CHCI
CHCI
GERN
GERN
Q4 25
$85.0M
Q3 25
$67.6M
$567.4M
Q2 25
$65.2M
$555.2M
Q1 25
$62.8M
$562.5M
Q4 24
$64.9M
Q3 24
$52.2M
$444.9M
Q2 24
$48.6M
$449.4M
Q1 24
$46.8M
$482.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCI
CHCI
GERN
GERN
Operating Cash FlowLast quarter
$4.8M
$-13.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.36×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCI
CHCI
GERN
GERN
Q4 25
$4.8M
Q3 25
$-3.2M
$-13.6M
Q2 25
$2.2M
$-27.4M
Q1 25
$582.0K
$-48.0M
Q4 24
$10.7M
Q3 24
$3.9M
$-58.9M
Q2 24
$1.3M
$-53.5M
Q1 24
$-2.2M
$-62.3M
Free Cash Flow
CHCI
CHCI
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
FCF Margin
CHCI
CHCI
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Capex Intensity
CHCI
CHCI
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Cash Conversion
CHCI
CHCI
GERN
GERN
Q4 25
0.36×
Q3 25
-5.96×
Q2 25
1.51×
Q1 25
0.37×
Q4 24
1.03×
Q3 24
1.63×
Q2 24
1.35×
Q1 24
-2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHCI
CHCI

Related Party$22.1M92%
Nonrelated Party$1.9M8%

GERN
GERN

Segment breakdown not available.

Related Comparisons